☆ 4.6 Review

Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems

FRONTIERS IN MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Rheumatology

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

Gyorgy Nagy et al.

Summary: The EULAR Task Force developed evidence-based points to consider for the management of difficult-to-treat rheumatoid arthritis, covering diagnostic confirmation, evaluation of inflammatory disease activity, pharmacological and non-pharmacological interventions, treatment adherence, functional disability, pain, fatigue, goal setting, self-efficacy, and impact of comorbidities. The strength of recommendations varied from level C to D, with a generally high level of agreement.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Rheumatology

Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

Saedis Saevarsdottir et al.

Summary: This study identified causal genes for rheumatoid arthritis (RA) and its subsets through a genome-wide association study. Most of these genes encode proteins related to interferon and IL-12/23 signaling, particularly in the JAK/STAT pathway. Variants in some of these genes were found to increase or decrease the risk of seropositive RA.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Review Rheumatology

Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search

Nadia M. T. Roodenrijs et al.

Summary: Management of RA patients has improved, but a substantial proportion of patients remain difficult to treat. Factors contributing to this difficulty include treatment non-adherence, comorbidities, and mimicking diseases. This review examines underlying immune mechanisms and discusses potential scenarios, suggesting that D2T RA is a syndrome involving different pathogenic mechanisms.

RHEUMATOLOGY (2022)

Add to Collection

Meeting Abstract Rheumatology

DRUG RETENTION OF BIOLOGICS OR JAK INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS FROM THE ANSWER COHORT

R. Watanabe et al.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Review Rheumatology

Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis

Yasmin Khader et al.

Summary: Biologics have shown effectiveness in treating rheumatoid arthritis (RA), although a significant proportion of patients do not respond to these treatments. A comprehensive literature review revealed that older age, female gender, obesity, smoking history, poor functional status, high disease activity, and elevated erythrocyte sedimentation rate are poor predictors of remission in RA patients treated with biologics, while positive anti-citrullinated protein antibodies were associated with a high remission rate.

CLINICAL RHEUMATOLOGY (2022)

Add to Collection

Article Immunology

Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis

Takeshi Iwasaki et al.

Summary: A multi-omics analysis of TNFi responses in a Japanese RA cohort revealed that the dynamics of the type I and II IFN pathways affected long-term responses to TNFi, providing information on its biological background and potential for clinical applications.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Rheumatology

'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps

Yvonne Tan et al.

Summary: This review summarises the key concepts of difficult to treat rheumatoid arthritis (D2T-RA) defined by the European Alliance of Associations for Rheumatology. D2T-RA is primarily characterized by the failure of at least two different mechanism of action drugs with evidence of active/progressive disease. The review suggests additional considerations in the definition of D2T-RA and the potential value of identifying D2T traits and intervening before the development of D2T-RA state.

RMD OPEN (2022)

Add to Collection

Article Rheumatology

Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis

Ichiro Yoshii et al.

Summary: This study evaluated the factors influencing the prognosis after the last b/tsDMARD treatment in patients with difficult-to-treat rheumatoid arthritis. The study found that patients with lower doses of GCS or MTX at the beginning of treatment were more likely to experience repeat D2T_RA, while patients with tightly controlled disease activity were more likely to withdraw from D2T_RA treatment.

RHEUMATOLOGY INTERNATIONAL (2022)

Add to Collection

Article Immunology

Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort

Ryu Watanabe et al.

Summary: Approximately 7.9% of patients with rheumatoid arthritis (RA) are diagnosed with difficult-to-treat RA (D2T RA). High rheumatoid factor (RF) levels, high DAS28-ESR, and coexisting pulmonary disease are predictive risk factors for D2T RA.

IMMUNOLOGICAL MEDICINE (2022)

Add to Collection

Article Rheumatology

Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry

Sae Ochi et al.

Summary: This study compared the responsiveness to various biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with difficult-to-treat rheumatoid arthritis. The results suggest that JAK inhibitors are a preferable treatment choice for this type of patients.

ARTHRITIS RESEARCH & THERAPY (2022)

Add to Collection

Review Rheumatology

EULAR definition of difficult-to-treat rheumatoid arthritis

Gyorgy Nagy et al.

Summary: The Task Force aimed to create recommendations for the underserved patient group with difficult-to-treat rheumatoid arthritis by drafting a definition based on international survey data among rheumatologists, nurses, health professionals, and patients. The definition includes specific criteria for treatment failure and symptom characteristics that are considered problematic by both the healthcare provider and the patient. This proposed EULAR definition can be applied in clinical practice, trials, and serve as a foundation for future research.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015

Bryant R. England et al.

Summary: The study found that the prevalence and burden of multimorbidity in patients with rheumatoid arthritis is significantly higher than in non-patients, and the progression of multimorbidity accelerates following the onset of rheumatoid arthritis.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

Markus Rehberg et al.

Summary: Machine learning was used to identify a rule to predict treatment response to sarilumab in rheumatoid arthritis patients, based on clinically feasible blood biomarkers. This individualized treatment approach could potentially improve outcomes for patients with rheumatoid arthritis.

RHEUMATOLOGY AND THERAPY (2021)

Add to Collection

Article Rheumatology

Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis

Weiyang Tao et al.

Summary: Machine learning models based on gene expression and DNA methylation profiling accurately predict response to anti-tumor necrosis factor treatment in rheumatoid arthritis patients. Differential transcription signatures were observed in PBMCs, monocytes, and CD4+ T cells between responders to different anti-TNF therapies. Differential methylated positions also played a role in predicting treatment response.

ARTHRITIS & RHEUMATOLOGY (2021)

Add to Collection

Review Rheumatology

Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis

Maya H. Buch et al.

Summary: This review focuses on two types of refractory rheumatoid arthritis (RA) patients: those with persistent inflammatory refractory RA (PIRRA) and those with non-inflammatory refractory RA (NIRRA). Identifying individuals with predominant PIRRA or NIRRA is crucial for informing distinct treatment and management approaches for refractory RA.

NATURE REVIEWS RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease

Nadia M. T. Roodenrijs et al.

Summary: The comprehensive study on D2T RA identified multiple contributing factors, a high burden of disease, and the heterogeneity of D2T RA subgroups. These findings suggest the importance of identifying these factors in daily practice to tailor therapeutic strategies to individual patients.

RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice

Satoshi Takanashi et al.

Summary: This study investigated the clinical characteristics of patients with difficult-to-treat RA and the effectiveness of switching to drugs with different modes of action. The results showed that 10.1% of patients were still difficult to treat, and while changing drugs was useful, the proportion of patients achieving remission or low disease activity decreased with each switch.

RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study

Nadia M. T. Roodenrijs et al.

Summary: The economic burden of difficult-to-treat rheumatoid arthritis (D2T RA) is significantly higher than that of non-D2T RA, indicated by higher healthcare utilization and annual total costs. Functional disability is a key determinant of higher costs in RA.

RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon

Marianne A. Messelink et al.

Summary: Using various techniques, we successfully identified and predicted potential new D2T RA patients in structured and unstructured routine care data, and developed a model for D2T RA identification. The promising results should be further optimized and validated in future research.

ARTHRITIS RESEARCH & THERAPY (2021)

Add to Collection

Review Rheumatology

Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis

Nadia M. T. Roodenrijs et al.

Summary: This study summarized the evidence on diagnostic issues in difficult-to-treat rheumatoid arthritis (D2T RA) and found a scarcity of high-quality studies, no diagnostic tests with sufficient validity and accuracy identified, with ultrasonography (US) showing promise for assessing inflammatory activity.

RMD OPEN (2021)

Add to Collection

Review Rheumatology

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis

Nadia M. T. Roodenrijs et al.

Summary: This systematic literature review highlights the lack of high-quality evidence on the treatment of patients with difficult-to-treat rheumatoid arthritis. The effectiveness of biologic/targeted synthetic DMARDs decreased in patients who had failed multiple previous treatments, but non-pharmacological interventions showed potential for improving non-inflammatory complaints and self-management.

RMD OPEN (2021)

Add to Collection

Article Rheumatology

Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network

Elena Nikiphorou et al.

RHEUMATOLOGY (2020)

Add to Collection

Review Rheumatology

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S. Smolen et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Add to Collection

Article Rheumatology

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis

Marta Novella-Navarro et al.

ARTHRITIS RESEARCH & THERAPY (2020)

Add to Collection

Article Rheumatology

Risk profiling for a refractory course of rheumatoid arthritis

Manuel Becede et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)

Add to Collection

Review Rheumatology

Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need

Maria J. H. de Hair et al.

RHEUMATOLOGY (2018)

Add to Collection

Article Rheumatology

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Lianne Kearsley-Fleet et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

Add to Collection

Article Medicine, General & Internal

Rheumatoid arthritis

Josef S. Smolen et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Add to Collection

Article Rheumatology

Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey

Nadia M. T. Roodenrijs et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

Add to Collection

Article Rheumatology

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Maxime Dougados et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Add to Collection

Review Rheumatology

Treating rheumatoid arthritis to target: recommendations of an international task force

Josef S. Smolen et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Add to Collection

Article Rheumatology

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.